---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-227647"
form_type: "8-K"
ticker: "RGNX"
cik: "0001590877"
company_name: "REGENXBIO Inc."
filed_at: "2023-09-01T23:59:59+00:00"
generated_at: "2026-06-11T00:31:04.061193+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# REGENXBIO enters into $150M ATM equity offering agreement with BofA Securities

## Summary
- May offer and sell common stock up to $150M aggregate price under ATM Sales Agreement with BofA Securities.
- Agent will receive commission up to 3% of gross proceeds; sales made at prevailing market prices.
- Company not obligated to sell any shares; agreement may terminate at any time by either party.
- Offering complements existing S-3 shelf registration filed December 30, 2022.
- BofA has provided and may continue providing investment banking and financial services to REGENXBIO.

## SEC filing metadata
- accession: 0001193125-23-227647
- form_type: 8-K
- ticker: RGNX
- cik: 0001590877
- company_name: REGENXBIO Inc.
- filed_at: 2023-09-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590877/000119312523227647/0001193125-23-227647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590877/000119312523227647/d548812d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-227647
- JSON: https://secwatch.observer/filing/0001193125-23-227647.json
- Plain text: https://secwatch.observer/filing/0001193125-23-227647.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.